Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
The FDA’s Evolving Approach to Drug Approval
Contributing Author John Vandermosten, Senior Biotechnology Analyst One hundred and fifty years ago, the world of medicine was radically different from today. The pharmaceutical market was dominated by powders, potions, elixirs and cordials that made extraordinary claims but rarely if ever had any scientific backing for…
Read More
2021 IPO & M&A Trends
Contributing Author John Vandermosten, Senior Biotechnology Analyst Transaction Trends 2021: Pandora’s Box 2020 was a tremendous year for Initial Public Offerings (IPOs) where 494 new issues came to market[1], but the achievement was eclipsed in 2021 with an all-time record of 1,058 companies going public. In…
Read More
Top Cell Therapy Approvals and Pipeline / Cell Therapy is More Than CAR T
Contributing Author John Vandermosten, Senior Biotechnology Analyst Cell therapy is the transfer of therapeutic cells to a patient. It replaces damaged cells or enhances normal cells with modified new ones.[1] The cells used in the process may be autologous or allogeneic; however, they must be recognized…
Read More
Dr. Marcus Conant, First Doctor to Diagnose HIV – Appointed As AGT Special Advisor to the CEO
Subscribe to our YouTube Channel Dr. Conant was the first physician to diagnose HIV in San Francisco while running the inpatient dermatology service at the University of California San Francisco. Before anyone recognized the virus or understood that it was about to become a global…
Read More
FDA Gene Therapy Approvals
Contributing Author John Vandermosten, Senior Biotechnology Analyst Despite the impact of the pandemic and the seemingly solitary focus of the health care machine on addressing SARS-CoV-2, the gene therapy space continued to progress over the last 18 months. Several new approvals were granted and promising candidates…
Read More
HIV Breakthrough at American Gene Technologies Gets Researchers Closer to the Cure
Subscribe to our YouTube Channel In May 2021, American Gene Technologies (AGT), a clinical-stage biotechnology company, announced the treatment of the first participant in its Phase I clinical trial to evaluate the safety of the cell and gene therapy product AGT103-T. Designated as the RePAIR…
Read More
HIV Cure Program Clinical Trial Update – Spring 2021
Subscribe to our YouTube Channel This April 2021, Kelly Huang, Ph.D., Sommar Nettles, M.Sc., and Anisha Mannan, M.Sc. from American Gene Technologies’ AGT103-T product team share clinical trial updates from Phase 1 of the drug product’s clinical trials for the HIV Cure Program. So far,…
Read More
Chapter IV: Solving The Riddle, A Consequential Approach
Contributing Author John Vandermosten, Senior Biotechnology Analyst The arc of HIV history has been developing over the last four decades. In the early days there was much we did not know, but as teams of physicians, researchers and patients increased their understanding of the disease, progress…
Read More
What Is CAR T-Cell Therapy? How It Works In 2-Minutes
Contributing Author : Gina Big Picture Cancer is a leading cause of death worldwide. In the U.S., only heart disease ranks above it. The American Cancer Society estimates that in the U.S. in 2021, there will be nearly 2 million new cancer cases and more…
Read More
What Is Stem Cell Therapy? How It Works In 2-Minutes
Contributing Author : Gina Big Picture Genomic medicine is bringing hope where none previously existed. This approach to cure and treat human diseases uses human biology rather than chemical compounds made in the lab to unlock techniques and therapies with the power to cure…
Read MoreSubscribe to Receive our Blog Updates
Subscribe to our blog updates to be notified when we release new content!
Blog Categories
Follow AGT on Social Media
AGT on Facebook
